Cardio Diagnostics Holdings, Inc. (CDIO) vs Pulmatrix, Inc. (PULM)
- Cardio Diagnostics Holdings, Inc. CDIO 1.69 −3.98%
- Pulmatrix, Inc. PULM 1.36 −3.55%
Cardio Diagnostics Holdings, Inc. and Pulmatrix, Inc. are both Biotechnology companies. Cardio Diagnostics Holdings, Inc. and Pulmatrix, Inc. are of similar size ($5.2M and $5.2M). Pulmatrix, Inc. grew revenue faster over the last twelve months: 6.96% against −25.1%. Pulmatrix, Inc. has the higher net margin (0.00% vs −44,312.3%) and the higher return on invested capital (0.00% vs −219.4%). Across the 15 metrics below, Pulmatrix, Inc. leads on 9 and Cardio Diagnostics Holdings, Inc. on 6.
Valuation
Profitability
| Metric | CDIO | PULM | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (44,230.82%) | 0.00% | 0.00% |
| Net margin | (44,312.33%) | 0.00% | 0.00% |
| Free cash flow margin | (39,893.15%) | 0.00% | 0.00% |
| Return on equity | (75.44%) | (111.99%) | (56.36%) |
| Return on assets | (70.62%) | (85.74%) | (48.04%) |
| Return on invested capital | (219.40%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack